Market Overview:
The global infectious immunology market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of infectious diseases, rising demand for advanced diagnostic kits and instruments, and growing awareness about preventive measures against infections. Based on type, the global infectious immunology market is segmented into diagnostic kits, instruments, and reagents. The diagnostic kit segment is further divided into ELISA kits, PCR kits, rapid test kits, and others. The instrument segment includes flow cytometers/cell sorters/immunophenotypers; spectrophotometers; microscopes; chromatography systems; gel electrophoresis systems; biosensors & biochips; and others.
Product Definition:
Infectious Immunology is the study of how infectious agents, such as bacteria and viruses, interact with the immune system. The importance of Infectious Immunology is that it helps us to understand how infections can be prevented or treated, and how the immune system works.
Diagnostic Kits:
A diagnostic kit is a set of reagents or instruments used for the detection of disease-causing microorganisms, chemicals, and other biological agents. The global infectious diseases market is expected to grow at a lucrative rate during the forecast period owing to increasing prevalence rates of HIV/AIDS, TB (tuberculosis), malaria & dengue fever along with rising demand for rapid diagnostic tests. Diagnostic kits are segmented into two types on the basis of technology and application.
Instruments:
Instruments and it's usage in infectious immunology market is used for detection, identification, quantification & study of microorganisms. It helps in understanding the mechanism of action & resistance to antibiotics. Instruments and it's usage in infectious immunology market are widely used by medical practitioners to treat several infections including pneumonia, urinary tract infection (UTI), skin infections & sexually transmitted diseases.
Application Insights:
The others segment includes infectious diseases that are caused by pathogens other than the five major groups of immunodeficiency diseases (HIV, HBV, HCV, TB and Pneumonia). The increasing number of research initiatives for the identification and characterization of new infectious disease agents is anticipated to boost segment growth during the forecast period.
The HIV/AIDS segment dominated the overall industry in terms of revenue generation in 2017. This can be attributed to a high prevalence rate coupled with an effective treatment regimen available for AIDS patients. Moreover, there has been significant progress made in recent years towards eliminating mother-to-child transmission through breastfeeding as well as promoting safe sex among individuals at risk of HIV infection. These factors are expected to drive demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a well-established healthcare infrastructure, high disease prevalence, and increasing R&D investments by private as well as public entities. Moreover, rising awareness about infectious diseases among people is anticipated to fuel growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare facilities and growing economic stability in emerging countries like China & India that are majorly affected by infectious diseases. Furthermore, an increase in government initiatives for controlling various infections is also expected favorably impact revenue generation during the same period. For instance; In 2014; The Indian Council of Medical Research (ICMR) launched a national program called “Swine Flu Immunization Program†which aimed at immunizing around 90 million children against H1N1 influenza virus infection across India within 6 months after its outbreak was declared worldwide pandemic by WHO (World Health Organization).
Growth Factors:
- Increasing incidence of infectious diseases: The global incidence of infectious diseases is increasing at a rapid pace. This is primarily due to the changing lifestyles and environmental conditions. Infectious immunology offers potential solutions for managing and preventing these infections.
- Growing demand for vaccines: The demand for vaccines is growing rapidly due to the increasing awareness about the benefits of vaccination among people across the world. Infectious immunology offers various innovative vaccine technologies that can help meet this growing demand.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and heart disease is rising at an alarming rate across the world. Infectious immunology offers potential solutions for managing and preventing these chronic infections effectively..
Scope Of The Report
Report Attributes
Report Details
Report Title
Infectious Immunology Market Research Report
By Type
Diagnostic Kits, Instruments, Reagents
By Application
HIV, TB, HBV and HCV, Pneumonia, Malaria, Inflammatory Bowel Diseases, Auto Immune Diseases, Others
By Companies
Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories, Dr. Reddy’s Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Infectious Immunology Market Report Segments:
The global Infectious Immunology market is segmented on the basis of:
Types
Diagnostic Kits, Instruments, Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
HIV, TB, HBV and HCV, Pneumonia, Malaria, Inflammatory Bowel Diseases, Auto Immune Diseases, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Roche Diagnostics
- Thermo Fisher Scientifics
- Bio-Rad Laboratories
- Dr. Reddy’s Laboratories
Highlights of The Infectious Immunology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Kits
- Instruments
- Reagents
- By Application:
- HIV
- TB
- HBV and HCV
- Pneumonia
- Malaria
- Inflammatory Bowel Diseases
- Auto Immune Diseases
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infectious Immunology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infectious immunology is the study of how infections and immune responses affect human health. Infections can cause serious health problems, including pneumonia, meningitis, and sepsis. The immune system plays a critical role in defending against infections by fighting off bacteria or viruses.
Some of the major companies in the infectious immunology market are Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientifics, Bio-Rad Laboratories, Dr. Reddy’s Laboratories.
The infectious immunology market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infectious Immunology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Infectious Immunology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Infectious Immunology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Infectious Immunology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Infectious Immunology Market Size & Forecast, 2018-2028
4.5.1 Infectious Immunology Market Size and Y-o-Y Growth
4.5.2 Infectious Immunology Market Absolute $ Opportunity
Chapter 5 Global Infectious Immunology Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Infectious Immunology Market Size Forecast by Type
5.2.1 Diagnostic Kits
5.2.2 Instruments
5.2.3 Reagents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Infectious Immunology Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Infectious Immunology Market Size Forecast by Applications
6.2.1 HIV
6.2.2 TB
6.2.3 HBV and HCV
6.2.4 Pneumonia
6.2.5 Malaria
6.2.6 Inflammatory Bowel Diseases
6.2.7 Auto Immune Diseases
6.2.8 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Infectious Immunology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Infectious Immunology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Infectious Immunology Analysis and Forecast
9.1 Introduction
9.2 North America Infectious Immunology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Infectious Immunology Market Size Forecast by Type
9.6.1 Diagnostic Kits
9.6.2 Instruments
9.6.3 Reagents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Infectious Immunology Market Size Forecast by Applications
9.10.1 HIV
9.10.2 TB
9.10.3 HBV and HCV
9.10.4 Pneumonia
9.10.5 Malaria
9.10.6 Inflammatory Bowel Diseases
9.10.7 Auto Immune Diseases
9.10.8 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Infectious Immunology Analysis and Forecast
10.1 Introduction
10.2 Europe Infectious Immunology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Infectious Immunology Market Size Forecast by Type
10.6.1 Diagnostic Kits
10.6.2 Instruments
10.6.3 Reagents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Infectious Immunology Market Size Forecast by Applications
10.10.1 HIV
10.10.2 TB
10.10.3 HBV and HCV
10.10.4 Pneumonia
10.10.5 Malaria
10.10.6 Inflammatory Bowel Diseases
10.10.7 Auto Immune Diseases
10.10.8 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Infectious Immunology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Infectious Immunology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Infectious Immunology Market Size Forecast by Type
11.6.1 Diagnostic Kits
11.6.2 Instruments
11.6.3 Reagents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Infectious Immunology Market Size Forecast by Applications
11.10.1 HIV
11.10.2 TB
11.10.3 HBV and HCV
11.10.4 Pneumonia
11.10.5 Malaria
11.10.6 Inflammatory Bowel Diseases
11.10.7 Auto Immune Diseases
11.10.8 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Infectious Immunology Analysis and Forecast
12.1 Introduction
12.2 Latin America Infectious Immunology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Infectious Immunology Market Size Forecast by Type
12.6.1 Diagnostic Kits
12.6.2 Instruments
12.6.3 Reagents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Infectious Immunology Market Size Forecast by Applications
12.10.1 HIV
12.10.2 TB
12.10.3 HBV and HCV
12.10.4 Pneumonia
12.10.5 Malaria
12.10.6 Inflammatory Bowel Diseases
12.10.7 Auto Immune Diseases
12.10.8 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Infectious Immunology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Infectious Immunology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Infectious Immunology Market Size Forecast by Type
13.6.1 Diagnostic Kits
13.6.2 Instruments
13.6.3 Reagents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Infectious Immunology Market Size Forecast by Applications
13.10.1 HIV
13.10.2 TB
13.10.3 HBV and HCV
13.10.4 Pneumonia
13.10.5 Malaria
13.10.6 Inflammatory Bowel Diseases
13.10.7 Auto Immune Diseases
13.10.8 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Infectious Immunology Market: Competitive Dashboard
14.2 Global Infectious Immunology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Roche Diagnostics
14.3.3 Thermo Fisher Scientifics
14.3.4 Bio-Rad Laboratories
14.3.5 Dr. Reddy’s Laboratories
